BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 9403715)

  • 1. Universal absence of merlin, but not other ERM family members, in schwannomas.
    Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
    Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system.
    Stemmer-Rachamimov AO; Gonzalez-Agosti C; Xu L; Burwick JA; Beauchamp R; Pinney D; Louis DN; Ramesh V
    J Neuropathol Exp Neurol; 1997 Jun; 56(6):735-42. PubMed ID: 9184664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
    Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
    J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
    Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
    Stemmer-Rachamimov AO; Ino Y; Lim ZY; Jacoby LB; MacCollin M; Gusella JF; Ramesh V; Louis DN
    J Neuropathol Exp Neurol; 1998 Dec; 57(12):1164-7. PubMed ID: 9862639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.
    Gutmann DH; Donahoe J; Perry A; Lemke N; Gorse K; Kittiniyom K; Rempel SA; Gutierrez JA; Newsham IF
    Hum Mol Genet; 2000 Jun; 9(10):1495-500. PubMed ID: 10888600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas.
    Gutmann DH; Giordano MJ; Fishback AS; Guha A
    Neurology; 1997 Jul; 49(1):267-70. PubMed ID: 9222206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
    Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
    Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
    Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
    Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.
    Kimura Y; Saya H; Nakao M
    Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Merlin/NF2 inactivation in tumor biology.
    Petrilli AM; Fernández-Valle C
    Oncogene; 2016 Feb; 35(5):537-48. PubMed ID: 25893302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezrin, radixin, and moesin are components of Schwann cell microvilli.
    Scherer SS; Xu T; Crino P; Arroyo EJ; Gutmann DH
    J Neurosci Res; 2001 Jul; 65(2):150-64. PubMed ID: 11438984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading.
    Gutmann DH; Sherman L; Seftor L; Haipek C; Hoang Lu K; Hendrix M
    Hum Mol Genet; 1999 Feb; 8(2):267-75. PubMed ID: 9931334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and distribution of NF2 mutations in schwannomas.
    Jacoby LB; MacCollin M; Barone R; Ramesh V; Gusella JF
    Genes Chromosomes Cancer; 1996 Sep; 17(1):45-55. PubMed ID: 8889506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis.
    Schulze KM; Hanemann CO; Müller HW; Hanenberg H
    Hum Mol Genet; 2002 Jan; 11(1):69-76. PubMed ID: 11773000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.
    Takeshima H; Izawa I; Lee PS; Safdar N; Levin VA; Saya H
    Oncogene; 1994 Aug; 9(8):2135-44. PubMed ID: 8035998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
    Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation.
    Huang J; Chen J
    Oncogene; 2008 Jul; 27(29):4056-64. PubMed ID: 18332868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.